CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
High-dose Sulbactam Treatment for Ventilator-Associated Pneumonia Caused by Carbapenem-Resistant Acinetobacter Baumannii
In Beom Jeong, Moon Jun Na, Ji Woong Son, Do Yeon Jo, Sun Jung Kwon
Acute and Critical Care. 2016;31(4):308-316.   Published online 2016 November 30    DOI: https://doi.org/10.4266/kjccm.2015.00703

Excel Download

High-dose Sulbactam Treatment for Ventilator-Associated Pneumonia Caused by Carbapenem-Resistant Acinetobacter Baumannii
The Korean Journal of Critical Care Medicine. 2016;31(4):308-316   Crossref logo
Link1 Link2 Link3

Outcome of High Dose Ampicillin-Sulbactam and Colistin Combination Therapy for Treating Ventilator-Associated Pneumonia Caused by Carbapenem-Resistant Acinetobacter baumannii: a Pilot Study
Pediatric Infection & Vaccine. 2020;27(1):45   Crossref logo
Link1 Link2 Link3

Efficacy and safety of high-dose ampicillin/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia
Journal of Infection. 2008;56(6):432-436   Crossref logo
Link1 Link2

Outcomes of Adjunctive Therapy with Intravenous Cefoperazone-Sulbactam for Ventilator-Associated Pneumonia Due to Carbapenem-Resistant Acinetobacter baumannii
Infection and Drug Resistance. 2021;Volume 14:1255-1264   Crossref logo
Link1 Link2

Comparison of colistin and colistin/sulbactam for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia
Infection. 2013;42(1):37-42   Crossref logo
Link1 Link2 Link3 Link4

Antimicrobial Treatment and Clinical Outcomes of Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia
Journal of Intensive Care Medicine. 2010;25(6):343-348   Crossref logo
Link1 Link2

Colistin and rifampicin combination in the treatment of ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii
International Journal of Antimicrobial Agents. 2008;32(3):281-284   Crossref logo
Link1 Link2

Clinical outcomes of colistin in combination with either 6-g sulbactam or carbapenems for the treatment of extensively drug-resistant Acinetobacter baumannii pneumonia with high MIC to sulbactam, a prospective cohort study
. 2019;   Crossref logo
Link1 Link2

Ventilator-associated pneumonia (VAP) caused by carbapenem-resistant Acinetobacter baumannii in patients with COVID-19: Two problems, one solution?
Medical Hypotheses. 2020;144:110139   Crossref logo
Link1 Link2

Colistin Dosage without Loading Dose Is Efficacious when Treating Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia Caused by Strains with High Susceptibility to Colistin
PLOS ONE. 2016;11(12):e0168468   Crossref logo
Link1

This metadata service is kindly provided by CrossRef from May 29, 2014. Acute Crit Care has participated in CrossRef Text and Data Mining service since March 1, 2015.